Xovoltib 40 Mg (Afatinib Dimaleate)

✅ Key Benefits

• Strong irreversible EGFR and HER2 blockade for high-tumor control

• Suitable for patients needing higher exposure when starting from 20 mg or 30 mg dosing

• Oral tablet supports consistent daily therapy

• Offers CNS penetration—useful for brain metastasis cases in responsive EGFR types

• Optimizes outcomes for treatment-resistant or aggressive mutations through higher dosing

🎯 How to Use

• Begin with one 40 mg tablet taken orally once daily, with or without food, at consistent time

• Continue therapy until disease progression or if side effects become intolerable

• Dose adjustments may be required—be prepared to reduce to 30 mg or 20 mg as needed for side effect management

• Frequent clinical monitoring is essential: liver function, skin, gastrointestinal health

⚠️ Precautions

• Prescription-only; ensure confirmed EGFR or HER2 mutation before use

• Higher dose increases risk of side effects such as diarrhea, rash, mucositis—manage proactively

• Periodic liver enzyme and kidney function checks recommended

• Monitor for cardiac or pulmonary risks—especially in patients with comorbidities

• Not safe for use during pregnancy—use effective contraception throughout therapy

🤕 Possible Side Effects

Common:

• Intense skin rash or acne-like lesions, diarrhea, mouth ulcers, paronychia, dry skin, fatigue

Less Common:

• Elevated liver enzymes, nausea, decreased appetite, mild weight changes, headache

Rare but Serious:

• Severe dehydration due to persistent diarrhea, hepatotoxicity, pneumonitis, QT prolongation or bradycardia

• Immediately report symptoms such as chest pain, yellowing skin/eyes, breathing trouble, dizziness, or extreme abdominal discomfort

🎁 Special Offers

• 💰 Up to 50% OFF sitewide

• 🚚 Free shipping on orders over ₹1999 (or equivalent)

• 📦 Discreet and secure packaging

• 🔐 Confidential checkout guaranteed

❓ Frequently Asked Questions (FAQs)

Q. Who should take Xovoltib 40 mg?
Intended for patients with advanced or metastatic NSCLC harboring EGFR mutations who require a maximal starting dose due to disease profile or previous dose escalation.

Q. Can the dose be reduced?
Yes, dose may be reduced to 30 mg or 20 mg daily based on patient tolerance or side effects.

Q. Should Xovoltib be taken with food?
It can be taken with or without food—maintaining consistent timing helps steady therapeutic exposure.

Q. What if I miss a dose?
Take it as soon as you remember unless it is near the next dose—never double up. Contact your doctor if multiple doses are missed.

Q. How are side effects managed at higher dosing?
Management may include dose reduction, temporary interruption, and supportive care (e.g. antidiarrheals, moisturizers, mouth rinses). Routine labs help detect serious adverse effects early.